US OptionsDetailed Quotes

GENE250117C7500

Watchlist

0.00
0.000.00%

15min DelayClose Jan 10 09:30 ET

0.00High0.00Low

Genetic Technologies Stock Discussion

71179109

Dec 13, 2024 10:37

Notice of Delisting from Nasdaq.Melbourne Australia, 13 December, 2024: Genetic Technologies Limited (Administrators Appointed) (ASX: GTG; NASDAQ: GENGTG;

$Genetic Technologies (GENE.US)$
Notice of Delisting from Nasdaq.Melbourne Australia, 13 December, 2024: Genetic Technologies Limited (Administrators Appointed) (ASX: GTG; NASDAQ: GENE) (“Genetic Technologies” or the “Company”) advices that the Company has received a Delisting Notice from Nasdaq Stock Market LLC (“Nasdaq”)relating, amo...

Jaguar8

Dec 12, 2024 19:10

🕗Watchlist FRIDAY December 13. NFA. Tired now so I’ll attach the watchlist for Thursday and Wednesday and check those which didn’t run yet. Remember it’s our lucky day tomorrow: Friday 13th

NOTE: Whenever a stock is up, make sure you check its dilution risk - cash on hand because most likely if they are cash-strapped, they will make offering. Scaling out is key. NEVER listen to those who say hold on because if you lose money, they wouldnt care AT ALL.
*************************************
REVERSE...

Trytosaveabit

Dec 12, 2024 16:49

New 6K

$Genetic Technologies (GENE.US)$ Notice of Delisting from Nasdaq and Failure to Satisfy a Continued Listing Rule or Standard.

Melbourne Australia, December 12, 2024: Genetic Technologies Limited (Administrators Appointed) (ASX: GTG; NASDAQ: GENE) (“Genetic Technologies” or the “Company”) previously announced on November 20, 2024 that Ross Blakeley and Paul Harlond of FTI Consulting had been appointed as Joint and Several Voluntary Administrators (“Administrators”) pursuant to section 436A...

Jaguar8

Oct 17, 2024 23:50

Watch this. On halt entire day. May be good or bad.

$Genetic Technologies (GENE.US)$

Trytosaveabit

Oct 17, 2024 05:41

T 1 news halt

$Genetic Technologies (GENE.US)$ 🤔

Trytosaveabit

Aug 14, 2024 18:49

Hmm

$Genetic Technologies (GENE.US)$ Genetic Technologies Launches Personalized Risk Testing on EasyDNA Platform
MT Newswires·
Genetic Technologies (ASX:GTG) launched the geneType Risk Assessment portfolio on its EasyDNA platform, according to a Thursday filing with the Australian Securities Exchange.
The availability of geneType on EasyDNA's consumer platform is expected to accelerate global access, potentially reaching 42 countries and generating annual revenues of AU$7.5 million, the filing sa...